Coramaze Technologies said it raised a $5 million (€4.5 million) Series A round for the transcatheter mitral valve implant it’s developing. The round was led by a $3.9 million (€3.5 million) contribution from Israel’s Elron Electronic Industries (TASE:ELRN), which said it now owns 28% of Munich-based Coramaze. Existing backers High-Tech Gründerfonds and SeedCapital Dortmund also participated with a pool of private investors, […]
Kyma Medical Technologies, a developer of remote cardiac monitoring devices, is entertaining a $35 million acquisition offer from an unnamed suitor, according to a regulatory filing by Elron Electronic Industries (TASE:ELRN), which owns a stake in Kyma. Kyma told Elron that it inked a non-binding letter of intent with “a non-affiliated 3rd party regarding a potential acquisition […]
Nanostim, the Sunnyvale, Calif.-based company that’s developing a leadless pacemaker, raised $10 million in an equity and options deal, according to a regulatory filing.
The Center for Health Transformation, a health care think tank launched by GOP presidential hopeful Newt Gingrich, filed for Chapter 7 bankruptcy this week, listing liabilities of between $1 million and $10 million that it says it can’t repay.
The organization’s assets, which it listed in court filings at between $50,000 and $100,000, will be liquidated and the business may subsequently close.
Intuitive Surgical (NSDQ:ISRG) won FDA clearance for its EndoWrist vessel sealer designed for use with the company’s da Vinci surgical robot.
The Sunnyvale, Calif.-based med-tech maker’s device is wristed to give clinicians full control over vessel sealing in vessels up to 7mm.
Welch Allyn president & CEO Julie Shimer announced plans to retire from the Skaneateles Falls, N.Y.-based diagnostics maker by the end of 2012.
Shimer became the first woman to hold the corner office at the 95-year old company when she took the position in 2007 after 5 years on the med-tech maker’s board of directors.
Urology diagnostics maker MedicaMetrix Inc. landed a $66,950 grant under the Medical Device Development Center’s "fast-lane" program to continue the development of its ProstaGlove for low cost detection of prostate cancer.
The grant was supported by the Massachusetts Technology Collaborative’s John Adams Innovation Institute.
Needle-free drug delivery company Bioject Medical Technologies (OTC:BJCT) announced the departure of its president & CEO "for cost-cutting reasons" on the heels of major cuts to its workforce.
Ralph Makar, who took the corner office at Bioject four years ago, ceded his role to board member Mark Logomasini, who will serve as interim president & CEO, effective immediately.
Shares of Mako Surgical (NSDQ:MAKO) are down 6.6 percent since the robotic surgery firm reported wider third-quarter losses, despite a nearly 67 percent increase in sales.
Mako reported losses of $9.7 million, or 24 cents per share, on sales of $20.0 million during the three months ended Sept. 30.